Normal view MARC view ISBD view

Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids. [electronic resource]

By:

Habjan, Suzanne

Contributor(s):

Vandenberg, Robert J

Producer: 20100423Description: 1738-47 p. digitalISSN:

1573-6903

Subject(s):

Online resources:

Available from publisher's website

In: Neurochemical research vol. 34

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1 Editorial: Happy New Year and a lifetime of journals.
by Paige, W H
2 Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.
by Wolstencroft, Paige W
3 Statistical analysis of the bioassay of continuous carcinogens.
by Peto, R
4 Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.
by Wolstencroft, Paige W
5 Sex differences in microglial colonization of the developing rat brain.
by Schwarz, Jaclyn M
6 Tracking procedures in follow-up studies of drug abusers.
by Goldstein, P J
7 Adverse events after vaccination among HIV-positive persons, 1990-2016.
by Su, John R
8 Provider perspectives on multilevel barriers to HPV vaccination.
by Lake, Paige W
9 Clinical factors associated with cutaneous histopathologic findings in dermatomyositis.
by Wolstencroft, Paige W
10 Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis.
by Wolstencroft, Paige W
11 Microglia and memory: modulation by early-life infection.
by Williamson, Lauren L
12 Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013.
by Sukumaran, Lakshmi
13 Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.
by Myers, Tanya R
14 Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016.
by Su, John R
15 Safety of Second-Dose Single-Antigen Varicella Vaccine.
by Su, John R
16 Exploring patient and provider perspectives on the intersection between fertility, genetics, and family building.
by Lake, Paige W
17 Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
by Haber, Penina
18 Applying Social Network Analysis to Evaluate Implementation of a Multisector Population Health Collaborative That Uses a Bridging Hub Organization.
by Leppin, Aaron L
19 Sex and estradiol influence glial pro-inflammatory responses to lipopolysaccharide in rats.
by Loram, Lisa C
20 Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
by Hutchinson, Mark R